These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28618901)

  • 1. Health inequalities in secondary prevention.
    Oertelt-Prigione S; Maas AH
    Eur J Prev Cardiol; 2017 Jun; 24(3_suppl):116-122. PubMed ID: 28618901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tackling inequalities: are secondary prevention therapies for reducing post-infarction mortality used without disparities?
    Buja A; Boemo DG; Furlan P; Bertoncello C; Casale P; Baldovin T; Marcolongo A; Baldo V
    Eur J Prev Cardiol; 2014 Feb; 21(2):222-30. PubMed ID: 22997352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lifestyle modification in secondary prevention.
    Piepoli MF; Villani GQ
    Eur J Prev Cardiol; 2017 Jun; 24(3_suppl):101-107. PubMed ID: 28618907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial/ethnic health disparities in cardiovascular disease during the COVID-19 pandemic: revisiting a long-lasting problem.
    Diaz CL; Watson KE
    Cardiovasc Res; 2022 Jan; 118(1):e8-e10. PubMed ID: 34747455
    [No Abstract]   [Full Text] [Related]  

  • 5. Best practice for prevention and treatment of cardiovascular disease through an equity lens: a review.
    Beauchamp A; Peeters A; Tonkin A; Turrell G
    Eur J Cardiovasc Prev Rehabil; 2010 Oct; 17(5):599-606. PubMed ID: 20562629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Most important articles on cardiovascular disease among racial and ethnic minorities.
    Mody P; Gupta A; Bikdeli B; Lampropulos JF; Dharmarajan K
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):e33-41. PubMed ID: 22811508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in reducing inequalities in cardiovascular disease mortality in Europe.
    Di Girolamo C; Nusselder WJ; Bopp M; Brønnum-Hansen H; Costa G; Kovács K; Leinsalu M; Martikainen P; Pacelli B; Rubio Valverde J; Mackenbach JP
    Heart; 2020 Jan; 106(1):40-49. PubMed ID: 31439656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How the American Heart Association helped change women's heart health.
    Brown N
    Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2 Suppl 1):S60-2. PubMed ID: 25714819
    [No Abstract]   [Full Text] [Related]  

  • 9. Gender, socioeconomic and ethnic/racial disparities in cardiovascular disease: a time for change.
    Ski CF; King-Shier KM; Thompson DR
    Int J Cardiol; 2014 Jan; 170(3):255-7. PubMed ID: 24238906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contemporary concepts in access to healthcare: Identification and elimination of disparities in care of minority patients.
    Nasser SA; Senatore FF
    Prog Cardiovasc Dis; 2020; 63(1):2-3. PubMed ID: 31816274
    [No Abstract]   [Full Text] [Related]  

  • 11. Importance of sex and gender in atherosclerosis and cardiovascular disease.
    Spence JD; Pilote L
    Atherosclerosis; 2015 Jul; 241(1):208-10. PubMed ID: 25980844
    [No Abstract]   [Full Text] [Related]  

  • 12. Socioeconomic status and health inequalities for cardiovascular prevention among elderly Spaniards.
    Mejía-Lancheros C; Estruch R; Martínez-González MA; Salas-Salvadó J; Corella D; Gómez-Gracia E; Fiol M; Lapetra J; Covas MI; Arós F; Serra-Majem L; Pintó X; Basora J; Sorlí JV; Muñoz MA;
    Rev Esp Cardiol (Engl Ed); 2013 Oct; 66(10):803-11. PubMed ID: 24773861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age and sex inequalities in the prescription of evidence-based pharmacological therapy following an acute coronary syndrome in Portugal: the EURHOBOP study.
    Pereira M; Araújo C; Dias P; Lunet N; Subirana I; Marrugat J; Capewell S; Bennett K; Azevedo A
    Eur J Prev Cardiol; 2014 Nov; 21(11):1401-8. PubMed ID: 23787795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex matters to the heart: A special issue dedicated to the impact of sex related differences of cardiovascular diseases.
    den Ruijter HM; Haitjema S; Asselbergs FW; Pasterkamp G
    Atherosclerosis; 2015 Jul; 241(1):205-7. PubMed ID: 26003338
    [No Abstract]   [Full Text] [Related]  

  • 15. Women and cardiovascular disease: an evidentiary review.
    Shirato S; Swan BA
    Medsurg Nurs; 2010; 19(5):282-6, 306. PubMed ID: 21189741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gendered innovation in cardiovascular science: implementation of sex and gender into clinical and biomedical research.
    Eifert S; Erdmann J; Hilfiker-Kleiner D
    Thorac Cardiovasc Surg; 2013 Jan; 61(1):4-6. PubMed ID: 23359368
    [No Abstract]   [Full Text] [Related]  

  • 17. [The program of lowering of residual vascular risk (The Residual Vascular Risk Reduction Initiative). Part II. Methods of correction].
    Zubareva MIu; Susekov AV
    Kardiologiia; 2010; 50(9):64-70. PubMed ID: 21118169
    [No Abstract]   [Full Text] [Related]  

  • 18. Heartbeat: reducing inequities in cardiovascular disease mortality.
    Otto CM
    Heart; 2020 Jan; 106(1):1-2. PubMed ID: 31843810
    [No Abstract]   [Full Text] [Related]  

  • 19. Eliminating racial and ethnic disparities in cardiac care.
    Peterson E; Yancy CW
    N Engl J Med; 2009 Mar; 360(12):1172-4. PubMed ID: 19297569
    [No Abstract]   [Full Text] [Related]  

  • 20. The UK National Health Service: delivering equitable treatment across the spectrum of coronary disease.
    Hawkins NM; Scholes S; Bajekal M; Love H; O'Flaherty M; Raine R; Capewell S
    Circ Cardiovasc Qual Outcomes; 2013 Mar; 6(2):208-16. PubMed ID: 23481523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.